RT Journal Article SR Electronic T1 A link between inflammatory biomarkers and lung ultrasound observations in patients with SARS-CoV-2 infection JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.06.22.20134270 DO 10.1101/2020.06.22.20134270 A1 Wangüemert Pérez, Aurelio Luis A1 Figueira Gonçalves, Juan Marco A1 Hernández Pérez, José María A1 Ramallo- Fariña, Yolanda A1 del Castillo Rodríguez, José Carlos YR 2020 UL http://medrxiv.org/content/early/2020/06/23/2020.06.22.20134270.abstract AB Lung ultrasound (LUS) has shown to correlate well with the findings obtained by chest computed tomography (CT) in acute-phase COVID-19. Although there is a significant correlation between blood biomarkers and CT radiological findings, a potential correlation between biochemical parameters and LUS images is still unknown. Our purpose was to evaluate a potential association between lung lesions visualised by LUS and blood biomarkers as well as the ability to predict mortality from two different lung ultrasound scoring systems (LUSS). We performed a retrospective observational study on 45 patients aged >70 years with SARS-CoV-2 infection who required hospitalisation. LUS was carried out at admission and on day 7, when the clinical course was favourable or earlier in case of worsening. Disease severity was scored by means of LUSS in 8 (LUSS8) and in 12 (LUSS12) quadrants. LUS and blood draw for inflammatory marker analysis were performed at the same time. The correlation between biochemical parameters and either LUSS score was significant for ferritin levels. It was 0.486 (p=0.001) for LUSS8 and 0.458 (p=0.002) for LUSS12. Using a threshold score of 15 with LUSS12 predicted mortality in 86.7% of cases (ORcrude 31, CI 95% 4.79–200.51). Applying a threshold of 10 with LUSS8 predicted mortality in 88.9% (ORcrude 69.75, CI 95% 6.90–705.20). There is a correlation between ferritin levels and LUSS. The prognostic capacity of LUSS12 does not surpass that of LUSS8.“Take-home message”There is a correlation between lung ultrasound scoring results and serum ferritin levels in patients with SARS-CoV-2 infection.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNone of the authors has received work endorsements, payments or external funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This work has been approved by the ethical committee of the University Hospital Nuestra Senora de la Candelaria with the code number: CHUNSC_2020_53All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThere is availability of all the data to which it refers